Cambridge Centre for Myelin Repair (renewal)

The Cambridge Centre for Myelin Repair is trying to find drugs that coax the brain's own cells to rebuild the protective fatty sheaths around nerve fibres—sheaths that are destroyed in multiple sclerosis (MS). This matters because MS currently has no cure, and existing treatments mostly dampen the immune system's attacks. Once the myelin is gone, nerve signals slow or stop, causing symptoms from numbness to paralysis. The centre's core insight is that effective repair therapies must come from a deep understanding of *how* remyelination works at a fundamental biological level—the "primary text" for translation. In this third phase, the team is also exploring a newer idea: that events outside the brain, such as changes in metabolism or the gut, can profoundly influence whether remyelination succeeds or fails inside the central nervous system. If the research succeeds, it could produce the first treatments that actually restore lost function in people with MS, rather than just preventing further damage. A major practical hurdle the centre is also tackling is the lack of agreed-upon ways to measure remyelination in clinical trials—without reliable outcome measures, even promising drugs cannot be proven to work.